DTE vs KALV
DTE (DTE) versus Kalvista Pharmaceuticals Inc (KALV) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
DTE does not have a complete income-statement cache yet.
Latest reported KALV revenue for 2025-09-30 was $13.7M. Net income was -$158.9M. KALV currently screens at market cap $1.44B.
DTE currently screens at market cap $0. KALV currently screens at market cap $1.44B.
Not investment advice. Open the DTE and KALV stock pages for the full models.
Not investment advice.